HALOZYME THERAPEUTICS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for HALOZYME THERAPEUTICS INC NOTE 1.000% 8/1, CUSIP 40637HAF6.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for HALOZYME THERAPEUTICS INC NOTE 1.000% 8/1, CUSIP 40637HAF6.